OnlyFibs
$TELA | Snapshot 📊⚡
• Business: TELA Bio, Inc., a commercial-stage medical technology company focused on surgical soft tissue reconstruction solutions (OviTex and LIQUIFIX).
• Financial Health & Pipeline: Targeted 8%+ full-year revenue growth supported by international market expansion, OviTex LTR adoption, and new sales force optimization.
• Bias & Conviction: Bullish Falling Channel Breakout | Moderate Conviction (Weekly chart attempting a trendline breakout directly out of high-volume support at $1.05–$1.20).
🎯 Key Levels:
🐂 Bull Trigger: $1.35 / $1.65
🚀 Targets: $1.65 / $2.10 / $3.00+
🛡️ Support: $1.10 / $1.05
⚠️ Risk: $0.80 / $0.65
#TELA #biotech #medtech #stocks #hovdid
